Peter Maag, Ph.D.
Peter Maag is the CEO of Kyverna Therapeutics. Dr. Maag has over 20 years of executive management experience in the pharmaceutical and diagnostics industries. He served previously as the CEO of CareDx. Prior to joining CareDx, he headed the expansion of Novartis’ diagnostics unit, with worldwide growth in its blood screening business and established new ventures in molecular diagnostics. Peter also led one of Novartis’ key affiliates as Country President, Germany, and lived in a dynamically growing and emerging market as Country President, Korea. At Novartis headquarters in Switzerland, he served as the Head of Strategy for Novartis Pharmaceuticals and helped launch the infectious diseases franchise.